Cargando…

Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial

BACKGROUND: Type 2 diabetes is an escalating public health problem in Nepal. The current study aims to assess the prevalence, associated factors, awareness, treatment, and control of type 2 diabetes in a semi-urban area of Nepal. METHODS: A population-based cross-sectional survey was conducted inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyawali, Bishal, Hansen, Martin Rune Hassan, Povlsen, Mia Buhl, Neupane, Dinesh, Andersen, Peter Krogh, McLachlan, Craig Steven, Sandbæk, Annelli, Vaidya, Abhinav, Kallestrup, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214524/
https://www.ncbi.nlm.nih.gov/pubmed/30388140
http://dx.doi.org/10.1371/journal.pone.0206491
_version_ 1783367984966795264
author Gyawali, Bishal
Hansen, Martin Rune Hassan
Povlsen, Mia Buhl
Neupane, Dinesh
Andersen, Peter Krogh
McLachlan, Craig Steven
Sandbæk, Annelli
Vaidya, Abhinav
Kallestrup, Per
author_facet Gyawali, Bishal
Hansen, Martin Rune Hassan
Povlsen, Mia Buhl
Neupane, Dinesh
Andersen, Peter Krogh
McLachlan, Craig Steven
Sandbæk, Annelli
Vaidya, Abhinav
Kallestrup, Per
author_sort Gyawali, Bishal
collection PubMed
description BACKGROUND: Type 2 diabetes is an escalating public health problem in Nepal. The current study aims to assess the prevalence, associated factors, awareness, treatment, and control of type 2 diabetes in a semi-urban area of Nepal. METHODS: A population-based cross-sectional survey was conducted including 2,310 adults aged 25 years or above from a semi-urban area of Lekhnath Municipality of Nepal, during October 2016 to April 2017 using the World Health Organization (WHO) STEPS approach. Data on demographics, behavioral risk factors, blood pressure, anthropometric measurements (weight, height, waist and hip circumference), and fasting blood glucose were collected by face-to-face interviews during a door-to-door visit. Participants were considered to have type 2 diabetes if they had previously been diagnosed by a physician and/or were on antidiabetic medications and/or had fasting blood glucose ≥ 7.0 mmol/L. Participants were classified as being aware of their diabetes conditions if they had earlier been told that they had type 2 diabetes. Treatment of diabetes among those aware was if participants received any kind of medication treatment or counseling, and control of diabetes among those treated was defined as fasting blood glucose level was <7.0 mmol/L. Odds Ratio (OR) with 95% Confidence Interval (CI) was used to determine the strength of association. RESULTS: The prevalence of type 2 diabetes was 11.7% (95% CI: 10.5–13.1). Among type 2 diabetes participants, 65% were aware of their disease, 94% of those who were aware received treatment, and 21% of the treated subjects had their diabetes under control. Factors significantly associated with type 2 diabetes were older age (OR = 3.2 for age group 45–54 years, OR = 3.8 for age group 55–64 years), Janajati ethnicity (OR = 1.4), abdominal obesity (OR = 2.3), being overweight or obese (OR = 1.4), and hypertension (OR = 2.0), while protective factors included being a female (OR = 0.4), medium physical activity (OR = 0.3), high physical activity (OR = 0.2), and not having family history of diabetes (OR = 0.3). CONCLUSIONS: The study revealed a high prevalence of type 2 diabetes among adults. Older age, male gender, Janajati ethnicity, abdominal obesity, overweight or obesity, hypertension, low physical activity, and family history of diabetes were associated with type 2 diabetes. Immediate public health and individual measures are warranted to reduce further burden of type 2 diabetes.
format Online
Article
Text
id pubmed-6214524
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62145242018-11-19 Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial Gyawali, Bishal Hansen, Martin Rune Hassan Povlsen, Mia Buhl Neupane, Dinesh Andersen, Peter Krogh McLachlan, Craig Steven Sandbæk, Annelli Vaidya, Abhinav Kallestrup, Per PLoS One Research Article BACKGROUND: Type 2 diabetes is an escalating public health problem in Nepal. The current study aims to assess the prevalence, associated factors, awareness, treatment, and control of type 2 diabetes in a semi-urban area of Nepal. METHODS: A population-based cross-sectional survey was conducted including 2,310 adults aged 25 years or above from a semi-urban area of Lekhnath Municipality of Nepal, during October 2016 to April 2017 using the World Health Organization (WHO) STEPS approach. Data on demographics, behavioral risk factors, blood pressure, anthropometric measurements (weight, height, waist and hip circumference), and fasting blood glucose were collected by face-to-face interviews during a door-to-door visit. Participants were considered to have type 2 diabetes if they had previously been diagnosed by a physician and/or were on antidiabetic medications and/or had fasting blood glucose ≥ 7.0 mmol/L. Participants were classified as being aware of their diabetes conditions if they had earlier been told that they had type 2 diabetes. Treatment of diabetes among those aware was if participants received any kind of medication treatment or counseling, and control of diabetes among those treated was defined as fasting blood glucose level was <7.0 mmol/L. Odds Ratio (OR) with 95% Confidence Interval (CI) was used to determine the strength of association. RESULTS: The prevalence of type 2 diabetes was 11.7% (95% CI: 10.5–13.1). Among type 2 diabetes participants, 65% were aware of their disease, 94% of those who were aware received treatment, and 21% of the treated subjects had their diabetes under control. Factors significantly associated with type 2 diabetes were older age (OR = 3.2 for age group 45–54 years, OR = 3.8 for age group 55–64 years), Janajati ethnicity (OR = 1.4), abdominal obesity (OR = 2.3), being overweight or obese (OR = 1.4), and hypertension (OR = 2.0), while protective factors included being a female (OR = 0.4), medium physical activity (OR = 0.3), high physical activity (OR = 0.2), and not having family history of diabetes (OR = 0.3). CONCLUSIONS: The study revealed a high prevalence of type 2 diabetes among adults. Older age, male gender, Janajati ethnicity, abdominal obesity, overweight or obesity, hypertension, low physical activity, and family history of diabetes were associated with type 2 diabetes. Immediate public health and individual measures are warranted to reduce further burden of type 2 diabetes. Public Library of Science 2018-11-02 /pmc/articles/PMC6214524/ /pubmed/30388140 http://dx.doi.org/10.1371/journal.pone.0206491 Text en © 2018 Gyawali et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gyawali, Bishal
Hansen, Martin Rune Hassan
Povlsen, Mia Buhl
Neupane, Dinesh
Andersen, Peter Krogh
McLachlan, Craig Steven
Sandbæk, Annelli
Vaidya, Abhinav
Kallestrup, Per
Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title_full Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title_fullStr Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title_full_unstemmed Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title_short Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial
title_sort awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of nepal: findings from a cross-sectional study conducted as a part of cobin-d trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214524/
https://www.ncbi.nlm.nih.gov/pubmed/30388140
http://dx.doi.org/10.1371/journal.pone.0206491
work_keys_str_mv AT gyawalibishal awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT hansenmartinrunehassan awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT povlsenmiabuhl awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT neupanedinesh awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT andersenpeterkrogh awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT mclachlancraigsteven awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT sandbækannelli awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT vaidyaabhinav awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial
AT kallestrupper awarenessprevalencetreatmentandcontroloftype2diabetesinasemiurbanareaofnepalfindingsfromacrosssectionalstudyconductedasapartofcobindtrial